Cargando…
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis
BACKGROUND: Worldwide, nifedipine and atosiban are the two most commonly used tocolytic agents for the treatment of threatened preterm birth. The aim of this study was to evaluate the effectiveness of nifedipine and atosiban in an individual participant data meta-analysis (IPDMA). METHODS: We invest...
Autores principales: | van Winden, Tijn M. S., Nijman, Tobias A. J., Kleinrouweler, C. Emily, Salim, Raed, Kashanian, Maryam, Al-Omari, Wafa R., Pajkrt, Eva, Mol, Ben W., Oudijk, Martijn A., Roos, Carolien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284745/ https://www.ncbi.nlm.nih.gov/pubmed/35840927 http://dx.doi.org/10.1186/s12884-022-04854-1 |
Ejemplares similares
-
Effects of tocolysis with nifedipine or atosiban on child outcome: follow‐up of the APOSTEL III trial
por: van Winden, TMS, et al.
Publicado: (2020) -
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)
por: van Vliet, Elvira OG, et al.
Publicado: (2014) -
Management of preterm labor: atosiban or nifedipine?
por: de Heus, Roel, et al.
Publicado: (2010) -
Atosiban-induced acute pulmonary edema: A rare but severe complication of tocolysis
por: Yang, Zuwei, et al.
Publicado: (2023) -
Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
por: Klumper, Job, et al.
Publicado: (2019)